Psychedelics Archives - Page 14 of 68

2 minute read

Optimi Health Will Supply Psychedelics To Canada’s SAP, Secures CA$1M Private Financing

September 8, 11:15 AM

Health Canada has approved an amendment to Optimi Health’s (OTCQX: OPTHF) dealer's license, effectively allowing the company to supply MDMA and psilocybin drugs to the country’s Special Access Program (SAP.)

OPTHF

2 minute read

Mushroom Foragers Warned AI-Written Books Can Be Potentially Dangerous

By El Planteo

September 7, 9:23 PM

Original story by Lucia Tedesco for El Planteo.

AMZN

2 minute read

Nasdaq Grants SpiSparc, Ltd. Extension To Maintain Listing: +600% Bid Price Surge Needed

By Lara Goldstein

September 7, 3:45 PM

Specialty clinical-stage biopharma company SciSparc Ltd. (NASDAQ: SPRC) has received a Nasdaq notice granting the company an additional 180-day compliance period until March 4 to regain compliance with the stock market’s minimum bid price rule.

AMZN

2 minute read

Johns Hopkins Will Work With Clearmind On Alcohol Addiction Research Program

By Lara Goldstein

September 6, 5:36 PM

Israeli psychedelics biotech Clearmind Medicine (NASDAQ: CMND) has inked a research agreement with Johns Hopkins University School of Medicine (JHU) to conduct the first-in-human Phase I/IIa clinical trial on its proprietary MEAI-based compound CMND-100 for the potential treatment of Alcoho

CMND

2 minute read

PharmaTher Aims To Mitigate Ketamine Shortage With New FDA Application

By Lara Goldstein

September 6, 5:21 PM

Specialty biotech company PharmaTher Holdings (OTCQB: PHRRF) reported it has submitted a priority-original Abbreviated New Drug Application (ANDA) for its proprietary racemic ketamine, KETARX, t

PHRRF

2 minute read

Compass Pathways Explores AI-Powered Predictive Model On Psilocybin Therapy For Depression

By Lara Goldstein

September 6, 4:10 PM

COMPASS Pathways plc (NASDAQ: CMPS) shared the results from research on the potential of its novel AI technologies to support its proprietary COM

CMPS

2 minute read

Cybin’s Intellectual Powerhouse Grows With New US Patent Covering Deuterated 5-MeO-DMT

By Lara Goldstein

September 5, 2:48 PM

The U.S. Patent and Trademark Office (USPTO) has granted Canada-based psychedelics company Cybin Inc. (NYSE: CYBN) a new patent covering the composition of matter of deuterated 5-MeO-DMT analogs and their pharmaceutical compositions with exclusivity until 2041.

CYBN

2 minute read

Elon Musk Calls Burning Man ‘Best Art On Earth’ Despite Chaos And Mass Exodus Of Attendees

By Lara Goldstein

September 5, 12:26 PM

This year’s version of the famed Nevada Burning Man event's chaos caused by “rare” rainfall and flooding starting last Friday, Sept. 1, attendees are finally getting out of the muddy mess and heading home.

TSLA

2 minute read

Treating PTSD Topically & Directly To The Brain? Psychedelics Delivery Company Poised For Major Breakthrough

By Maureen Meehan

September 3, 2:45 PM

Psycheceutical Bioscience, Inc (OTCPK: BWVI) is a cutting-edge biotech startup that developed a topical drug delivery system called NeuroDirect, a system that can be used to deliver psychedelic drugs directly to the brain, avoiding the traditional “high” and side effects.

BWVI

2 minute read

Pete Davidson Reveals He’s Tried Ketamine To Cope With Depression

By Lara Goldstein

September 1, 3:56 PM

News of psychedelics and who is using them keeps making headlines.

JNJ